|
|
Volumn 6, Issue 1, 2007, Pages 19-20
|
|
The antibacterial drugs market
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIINFECTIVE AGENT;
AZITHROMYCIN;
CARBAPENEM;
CEFTOBIPROLE;
CEPHALOSPORIN DERIVATIVE;
CETHROMYCIN;
CLARITHROMYCIN;
DALBAVANCIN;
DIHYDROFOLATE REDUCTASE INHIBITOR;
DORIPENEM;
ICLAPRIM;
KETOLIDE;
LEVOFLOXACIN;
LINEZOLID;
MACROLIDE;
MOXIFLOXACIN;
PENICILLIN DERIVATIVE;
POLYPEPTIDE ANTIBIOTIC AGENT;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
TELAVANCIN;
UNCLASSIFIED DRUG;
ZEVEN;
ABDOMINAL INFECTION;
BACTERIAL INFECTION;
CLINICAL TRIAL;
COMMUNITY ACQUIRED PNEUMONIA;
DRUG CLASSIFICATION;
DRUG COST;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG RESEARCH;
GRAM NEGATIVE BACTERIUM;
GRAM POSITIVE BACTERIUM;
HUMAN;
LICENSING;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
NOTE;
PATENT;
PRIORITY JOURNAL;
REIMBURSEMENT;
RESPIRATORY TRACT INFECTION;
SKIN INFECTION;
TREATMENT INDICATION;
URINARY TRACT INFECTION;
ANTI-BACTERIAL AGENTS;
BACTERIAL INFECTIONS;
CROSS INFECTION;
DRUG INDUSTRY;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
PATENTS;
RESEARCH;
|
|
EID: 33845880861
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd2226 Document Type: Note |
|
Times cited : (71)
|
|
References (2)
|
